Company
Andromeda Surgical
Andromeda Surgical is a South San Francisco-based startup building autonomous AI-guided surgical robots, founded in 2023 by Nick Damiano (CEO) and Kartik…
- Founded
- 2023
- HQ
- South San Francisco, CA, USA
- Funding
- $500,000
- Models
- 1
Verified profile
1
Sources on record
0
Tracked changes
Updated recently
Last verified change
Overview
Andromeda Surgical is a South San Francisco-based startup building autonomous AI-guided surgical robots, founded in 2023 by Nick Damiano (CEO) and Kartik Tiwari (CTO) through Y Combinator's Summer 2023 batch. The company's software-first platform uses off-the-shelf robotic arms paired with proprietary AI-driven localization and navigation to augment surgeons during natural orifice procedures, starting with HoLEP (holmium laser enucleation of the prostate). Andromeda completed the world's first robotic-assisted HoLEP procedure in 2024 and is running the ASTRA clinical trial, with partnerships including Richard Wolf and Quanta System.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Models (1)
View all models →Relationships
Current leadership (2)
- Nick Damiano CEO & Co-founderreported, not verified
- Kartik Tiwari CTO & Co-founderreported, not verified
Founders (2)
- Nick Damianocofounder
- Kartik Tiwaricofounder
Safety record
No incidents on record for Andromeda Surgical.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Andromeda Surgical in third-party press
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Neocis2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model
Financial state
- Reporting basis
- private_reported
- Revenue disclosed
- $1500000 (private_reported)
- Lifecycle stage
- early
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Seed2023-08-29
$500,000(reported)
Investors: Y Combinator, WestWave Capital, Attack Capital
Sources (1)
Common questions
- What is Andromeda Surgical?
- Andromeda Surgical is a South San Francisco-based startup building autonomous AI-guided surgical robots, founded in 2023 by Nick Damiano (CEO) and Kartik Tiwari (CTO) through Y Combinator's Summer 2023 batch. The company's software-first platform uses off-the-shelf robotic arms paired with proprietary AI-driven localization and navigation to augment surgeons during natural orifice procedures, starting with HoLEP (holmium laser enucleation of the prostate). Andromeda completed the world's first robotic-assisted HoLEP procedure in 2024 and is running the ASTRA clinical trial, with partnerships including Richard Wolf and Quanta System.
- Where is Andromeda Surgical based?
- Andromeda Surgical is based in South San Francisco, CA, USA.
- When was Andromeda Surgical founded?
- Andromeda Surgical was founded in 2023.
- What does Andromeda Surgical make?
- Andromeda Surgical has 1 robot model on the DEPLOY registry: Andromeda Surgical Robot (Andromeda Surgical builds physical robots).
- Where does Andromeda Surgical operate robots?
- Andromeda Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Andromeda Surgical safe?
- Andromeda Surgical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-06
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-06
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Andromeda Surgical.Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Neocis2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model
In the press
Recent coverage mentioning Andromeda Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
Andromeda Surgical: Funding, Team & Investors
Andromeda Surgical completed the world's first robotic-assisted HoLEP procedure at Universidad Catolica in Chile, with $1.5M revenue and partnerships with Richard Wolf and Quanta…
Andromeda Surgical: Autonomous surgical robots
Andromeda Surgical launched in YC Summer 2023 batch, building autonomous surgical robots that use AI to make surgery cognitively easier, starting with HoLEP (prostate enucleation)…
Our Investment in Andromeda Surgical: AI Robots for surgery
Attack Capital announced investment in Andromeda Surgical, noting founders Nick Damiano (Zenflow, Avail Medsystems) and Kartik Tiwari (Starsky Robotics) combine medtech and…
Machine-readable surfaces
- Markdown mirror: /companies/andromeda-surgical.md
- RSS feed: /companies/andromeda-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/bf2d14eb-db65-4c5f-9110-dddcb2c08c70
- Revision history: /companies/andromeda-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Neocis2 models
- Stryker2 models
- Vantis2 models
- Asensus Surgical1 model